Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 23, 2015Cytometry Part B Clinical CytometryOpen Access

Principles of minimal residual disease detection for hematopoietic neoplasms by flow cytometry

View Full Paper
Ask AI
Bookmark
Share

Authors

BWBrent L. WoodGoethe University Frankfurt

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brent L. Wood (2015) studied this question.

synapsesocial.com/papers/6a10ed8992dd5d7437ee3869https://doi.org/10.1002/cyto.b.21239
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission2013 · 362 citations
  2. 2Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia2013 · 3,534 citations
  3. 3Defining consensus leukemia-associated immunophenotypes for detection of minimal residual disease in acute myeloid leukemia in a multicenter setting2013 · 74 citations
  4. 4Modulation of antigen expression in B‐cell precursor acute lymphoblastic leukemia during induction therapy is partly transient: Evidence for a drug‐induced regulatory phenomenon. Results of the AIEOP‐BFM‐ALL‐FLOW‐MRD‐Study Group2010 · 97 citations
  5. 5Detection of Minimal Residual Disease in B Lymphoblastic Leukemia by High-Throughput Sequencing of IGH2014 · 170 citations